Transaction in Own Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail4 November 2026
Transactions in own shares and completion of the
share buyback programme
Admiral Group plc (the “Company”) announces that for the period 28 October 2026 to 03 November 2026 it has purchased for cancellation 206,046 of its ordinary shares of 0.1 pence each (“ordinary shares”), as detailed below, through the Company’s broker UBS AG, London Branch ("UBS") as part of its buyback programme announced on 30 September 2026.
| Date of Purchase | Number of Ordinary shares purchased | Volume weighted average price (pence) | Highest Price per share (pence) | Lowest Price per share (pence) | Trading venue |
| 28 October 2026 | 22,000 | 3,792.1773 | 3,812.00 | 3,772.00 | London Stock Exchange |
| 28 October 2026 | 19,000 | 3,792.6495 | 3,812.00 | 3,772.00 | BATS Europe |
| 28 October 2026 | 6,000 | 3,793.6660 | 3,812.00 | 3,774.00 | Chi-X Europe |
| 28 October 2026 | 3,000 | 3,792.8807 | 3,810.00 | 3,778.00 | Aquis |
| 29 October 2026 | 22,000 | 3,809.7962 | 3,836.00 | 3,788.00 | London Stock Exchange |
| 29 October 2026 | 19,000 | 3,812.7504 | 3,836.00 | 3,788.00 | BATS Europe |
| 29 October 2026 | 6,000 | 3,811.9353 | 3,834.00 | 3,790.00 | Chi-X Europe |
| 29 October 2026 | 3,000 | 3,809.1147 | 3,824.00 | 3,798.00 | Aquis |
| 30 October 2026 | 22,000 | 3,884.6121 | 3,904.00 | 3,852.00 | London Stock Exchange |
| 30 October 2026 | 19,000 | 3,884.9276 | 3,904.00 | 3,858.00 | BATS Europe |
| 30 October 2026 | 6,000 | 3,884.5953 | 3,900.00 | 3,870.00 | Chi-X Europe |
| 30 October 2026 | 3,000 | 3,886.0493 | 3,900.00 | 3,872.00 | Aquis |
| 02 November 2026 | 22,000 | 3,855.8516 | 3,870.00 | 3,826.00 | London Stock Exchange |
| 02 November 2026 | 19,000 | 3,856.8592 | 3,872.00 | 3,830.00 | BATS Europe |
| 02 November 2026 | 6,000 | 3,856.0333 | 3,870.00 | 3,826.00 | Chi-X Europe |
| 02 November 2026 | 3,000 | 3,856.4927 | 3,868.00 | 3,846.00 | Aquis |
| 03 November 2026 | 6,046 | 3,897.6494 | 3,906.00 | 3,886.00 | London Stock Exchange |
The Company intends to cancel all of the purchased ordinary shares.
Following the cancellation of the repurchased shares reported above, the Company’s issued share capital will consist of 305,098,630 ordinary shares with voting rights.
There are no ordinary shares held in Treasury.
The above figure (305,098,630) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The Company announces that, following the purchase of these shares, the share buyback programme announced on 30 September 2026 has completed. Since the commencement of the buyback, the Company has repurchased for cancellation 1,206,046 ordinary shares at a volume weighted average price of 3,731.2 pence per ordinary share for a total consideration of approximately £45 million.
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, a full breakdown of the individual purchases of ordinary shares made by UBS on behalf of the Company can be found in the link to this announcement.
Admiral Share Purchases 28.10.26 - 03.11.26
- ENDS -
For further information, please contact:
Media:
Addy Frederick [email protected]
Investors/ Analysts:
Jelena Bjelanovic [email protected]
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VEON’s Banglalink Launches Mukto Pay, Expanding Digital Financial Services in Bangladesh
- Nxera Pharma Enters into Global License Agreement with AbbVie for NXE0033744, a Novel EP4 Receptor Agonist for Inflammatory Bowel Disease
- PRE ANNOUNCEMENT OF CERTIFICATE AUCTION TENDER
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
UBS, Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
